Entering text into the input field will update the search result below

FDA OKs expanded use for Edwards' SAPIEN 3 heart valve

  • The FDA approves the use of Edwards Lifesciences' (EW +2.1%) SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Heart Valve Systems for the treatment of aortic stenosis (narrowing of the aortic valve restricting blood flow) in patients at low risk for surgical intervention.
  • The devices were previously approved for patients at intermediate or greater risk for surgery.

Recommended For You

About EW Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EW--
Edwards Lifesciences Corporation